Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-11-03
1999-12-07
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 5142392, 514319, 514428, 540596, 540612, 544146, 544153, 544398, 546202, 546205, 548525, 549 51, A61K 31445, C07D40912
Patent
active
059984414
ABSTRACT:
A method for alleviating the symptoms of post-menopausal syndrome comprising administering to a woman in need thereof an effective amount of a compound of formula I ##STR1## wherein R.sup.1a is --H or --OR.sup.7a in which R.sup.7a is --H or a hydroxy protecting group;
REFERENCES:
patent: 3293263 (1966-12-01), Lednicer
patent: 3320271 (1967-05-01), Lednicer
patent: 3394125 (1968-07-01), Crenshaw
patent: 3413305 (1968-11-01), Crenshaw
patent: 3862232 (1975-01-01), Lednicer
patent: 4117128 (1978-09-01), Brenner
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4418068 (1983-11-01), Jones
patent: 4910212 (1990-03-01), Boyle et al.
patent: 5013761 (1991-05-01), Beedle et al.
patent: 5223510 (1993-06-01), Gubin et al.
patent: 5254568 (1993-10-01), Kapil et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5488058 (1996-01-01), Palkowitz
patent: 5492922 (1996-02-01), Palkowitz
patent: 5510357 (1996-04-01), Palkowitz
patent: 5510498 (1996-04-01), Palkowitz
see copies in SN 08552,565.
Chritman et a; "chemotherapy of metastatic breast cancer in the elderly. . . " AMA abstract, 1992.
Need et al. "Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women" Index Medicus 87:01037, 1987.
Soma et al. "Hormonal agents used in lowerinf lipoprotein(a)"Medline 94243983, 1994.
Oparil "Hypertension in postmenopausal women:pathophysiology an management" EMBase 95:283951, 1995.
Sitruk-Ware "Menopause withich progestin to use interest of medgrogestone colprone in hormone replacement therapy" BA 85:061565, 1987.
Wyngaarden "Cecil textbook of medicine" p. 1090 1983.
Crenshaw, R.R., et al., J. Med. Chem., 14 (12) : 1185-1190 (1971).
Durani, N., et al., Indian J. Chem., 22B:489-490 (1983).
Jones, C.D., et al., J. Med. Chem., 35:931-938 (1992).
Lednicer, D., et al., J. Med. Chem., 8:52-57 (1964).
Madesclaire, M., Tetrahedren, 42 (20); 5459-5495 (1986).
Trost, B.M., et al., Tetrahedren Letters, 22 (14) ; 1287-1290 (1981).
Drabowicz, J, et al., Synthetic Communications, 11 (12) ; 1025-1030 (1981).
Kramer, J.B., et al. 34th National Organic Symposium, Williamsburg, VA, (Jun. 11-15, 1995).
Wyngaarden, et al., Cecil Textbook of Medicine, 16: 1271 (1983).
Boudreaux William R.
Chang Ceila
Eli Lilly and Company
LandOfFree
Benzothiophene compounds, intermediates, compositions, and metho does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiophene compounds, intermediates, compositions, and metho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiophene compounds, intermediates, compositions, and metho will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-824298